Contineum Therapeutics Launches 2026 Inducement Equity Incentive Plan
I'm PortAI, I can summarize articles.
Contineum Therapeutics Inc. has launched the 2026 Employment Inducement Equity Incentive Plan, reserving 750,000 shares of Class A common stock for equity awards. This plan allows stock options and restricted stock units for new employees, similar to the 2024 plan but excluding incentive stock options. Full details will be in the upcoming annual report. This news was generated by Public Technologies and is for informational purposes only, not financial or legal advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments